Tonix Pharmaceuticals receives Paragraph IV notice for TONMYA generic
Tonix Pharmaceuticals has received a Paragraph IV ANDA notice from Dr. Reddy’s for a generic version of TONMYA sublingual tablets, 2.8 mg.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.